Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Clinical Features and Natural Histry of Progressive Supranuclear Palsy, A Clinical Cohort Study
Neurol 60:910-916, Nath,W.,et al, 2003
The Accuracy of the Diagnosis of Paroxysmal Events in Children
Neurol 60:979-982, Stroink,H.,et al, 2003
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
NEJM 348:1215-1222, 1277, Vermeer,S.E.,et al, 2003
The 12 Year Prognosis of Unilateral Functional Weakness and Sensory Disturbance
JNNP 74:591-596,557, Stone,J.,et al, 2003
Status Epilepticus: A Review of Different Syndromes, Their Current Evaluation, and Treatment
The Neurologist 9:61-76, Gaitanis,J.N. &Drislane,F.W., 2003
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Primary Lateral Sclerosis
Neurol 60:1258-1265, Zhai,P.,et al, 2003
Outcome of Trigeminal Nerve Section in the Treatment of Chronic Cluster Headache
Neurol 60:1360-1362, Jarrar,R.G.,et al, 2003
Why Should Neuroradiologist Study Patients with Smell Loss?
AJNR 24:556-557, Levy,L.M.&Henkin,R.I., 2003
Safety and Feasibility of a CT Protocol for Acute Stroke: Combined CT, CT Angiography, and CT Perfusion Imaging in 53 Consecutive Patients
AJNR 24:688-690, Smith,W.S.,et al, 2003
Intellectual Impairment in children with Blood Lead Concentrations Below 10 ug per Deciliter
NEJM 348:1517-1526,1515, Canfield,R.L.,et al, 2003
Smallpox, Bioterrorism, and the Neurologist
Arch Neurol 60:489-494, Cleri,D.J.,et al, 2003
Neurologic Complications of Anthrax
Arch Neurol 60:483-488, Meyer,M.A., 2003
Parkinson Disease With Old-Age Onset
Arch Neurol 60:529-533, Diederich,N.J.,et al, 2003
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Proton MR Spectroscopy in the Diagnostic Evaluation of Suspected Mitochondrial Disease
AJNR 24:33-41, Lin,D.D.M.,et al, 2003
Carotid Dissection with Permanent and Transient Occlusion or Severe Stenosis
Neurol 60:271-275, Kremer,C.,et al, 2003
Rapidly Reversible Dementia
Lancet 361:392, Bernstein,R.,et al, 2003
Seizure Frequency is Associated with Age at Menopause in Women with Epilepsy
Neurol 61:451-455, Harden,C.L.,et al, 2003
Donepezil in Vascular Dementia
Neurol 61:479-486,429, Helme,R.,et al, 2003
Lupus and Zoster
Lancet 362:616, Douglas,K.M.J., 2003
Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter Gene ABCB1
NEJM 348:1442-1448,1480, Siddiqui,A.,et al, 2003
Anticoagulation for Cerebral Sinus Thrombosis
Stroke 34:1054-1055, Stam,J.,et al, 2003
Nosocomial Pneumonia After Acute Stroke
Stroke 34:975-981, Hilker,R.,et al, 2003
Emergency Calls in Acute Stroke
Stroke 34:1005-1009, Handschu,R.,et al, 2003
Statin-Associated Myopathy
JAMA 289:1681-1690, Thompson,P.D.,et al, 2003
Alzheimer's Disease and Parkinson's Disease
NEJM 348:1356-1364, Nussbaum,R.L. &Ellis,C.E., 2003
Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
Stroke 34:1106-1113, Heuschmann,P.U.,et al, 2003
Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003
Surgical Decompression for Cerebral Edema in Acute Ischemic Stroke
Stroke 34:1337, Morley,N.C.D.,et al, 2003
Long-term Outcome of Benign Paroxysmal Positional Vertigo
Neurol 60:1532-1534, Sakaida,M.,et al, 2003
Proton MR Spectroscopy in Wernicke Encephalopathy
AJNR 24:952-955, Rugilo,C.A.,et al, 2003
Proton MR Spectroscopy of Gliomatosis Cerebri: Case Report of Elevated Myoinositol with Normal Choline Levels
AJNR 24:946-951, Saraf-Lavi,E.,et al, 2003
Variable Presentation of Brugada Syndrome: Lessons from Three Generations with Syncope
BMJ 326:1078-1079, Plunkett,A.,et al, 2003
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 289:2651-2662,2717, Shumaker,S.A.,et al, 2003
Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women
JAMA 289:2663-2672,2717, Rapp,S.R.,et al, 2003
Rates and Predictors for Relapse in Medication Overuse Headache: A 1-year Prospective Study
Neurol 60:1682-1683, Katsarava,Z.,et al, 2003
Stroke Following Bothrops spp. Snakebite
Neurol 60:1577-1580, Mosquera,A.,et al, 2003
Immediate Reocclusion Following a Successful Thrombolysis in Acute Stroke: A Pilot Study
Neurol 60:1684-1687, Heo,J.H.,et al, 2003
Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients
NEJM 348:2196-2203, Iwamoto,M.,et al, 2003
Neurologic Manifestations of Vitamin B12 Deficiency
NEJM 348:2208, Scherer,K., 2003
Intra-arterial Thrombolysis in 24 Consecutive Patients with Internal Carotid Artery T Occlusions
JNNP 74:739-742, Arnold,M.,et al, 2003
Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003
Oral Anticoagulation in Patients After Cerebral Ischemia of Arterial Origin and Risk of Intracranial Hemorrhage
Stroke 34:e45, ESPRIT, 2003
Bacterial Meningitis in Children
Lancet 361:2139-2148, Saez-Llorens,X. &McCracken,G.H. Jr., 2003
The Outcome of Neurology Outpatients with Medically Unexplained Symptoms: A Prospective Cohort Study
JNNP 74:897-900,842, Carson,A.J.,et al, 2003